Rep. Norm Thurston — Voting Record

Utah House District 62 · complete roll-call record from le.utah.gov
← All votes

Bill

Controlled Substance Database Act Amendments
Number
H.B. 127 Second Substitute (2018GS)
Sponsor
Rep. Fawson, J.
Final action
Governor Signed 3/20/2018
Outcome
Became law — signed by Gov. Gary R. Herbert

Summary

This bill amends portions of the Controlled Substance Database Act.

What it does

  • This bill:
  • changes the requirements for checking the controlled substance database;
  • delays enforcement of the requirements in this bill to check the controlled substance database;
  • modifies the authority of the Division of Occupational and Professional Licensing to review the controlled substance database to identify any prescriber who may be overprescribing opioids;
  • grants the Division of Occupational and Professional Licensing the authority to provide education or training to certain prescribers and to take other enforcement action; and
  • modifies enforcement provisions.

Every vote on this bill

2/20/2018House Comm - Substitute Recommendation from # 0 to # 1
House Business and Labor Committee
9 0 5not eligible / no record
2/20/2018House Comm - Favorable Recommendation
House Business and Labor Committee
9 0 5not eligible / no record
2/27/2018House/ passed 3rd reading
Senate Secretary
66 4 5YEA
3/5/2018Senate Comm - Favorable Recommendation
Senate Business and Labor Committee
5 0 3not eligible / no record
3/7/2018House/ concurs with Senate amendment
Senate President
64 3 8YEA
3/7/2018Senate/ passed 2nd & 3rd readings/ suspension
Senate President
17 4 8not eligible / no record
3/7/2018Senate/ motion to reconsider
Senate Secretary
Voice votenot eligible / no record
3/7/2018Senate/ substituted from # 1 to # 2
Senate 3rd Reading Calendar
Voice votenot eligible / no record
3/7/2018Senate/ passed 3rd reading
Clerk of the House
25 2 2not eligible / no record

Bill text

enrolled version · official source
CONTROLLED SUBSTANCE DATABASE ACT AMENDMENTS
GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Justin L. Fawson
Senate Sponsor: 
Curtis S. Bramble
LONG TITLE
General Description:
This bill amends portions of the Controlled Substance Database Act.
Highlighted Provisions:
This bill:
▸ changes the requirements for checking the controlled substance database;
▸ delays enforcement of the requirements in this bill to check the controlled substance
database;
▸ modifies the authority of the Division of Occupational and Professional Licensing
to review the controlled substance database to identify any prescriber who may be
overprescribing opioids;
▸ grants the Division of Occupational and Professional Licensing the authority to
provide education or training to certain prescribers and to take other enforcement
action; and
▸ modifies enforcement provisions.
Money Appropriated in this Bill:
None
Other Special Clauses:
None
Utah Code Sections Affected:
AMENDS:
58-37f-304
, as last amended by Laws of Utah 2017, Chapters 181 and 237
58-37f-701
, as last amended by Laws of Utah 2016, Chapter 275
Be it enacted by the Legislature of the state of Utah:
Section 1. Section 
58-37f-304
 is amended to read:
58-37f-304.
Database utilization.
(1) As used in this section:
(a) "Dispenser" means a licensed pharmacist, as described in Section 
58-17b-303
, or
the pharmacist's licensed intern, as described in Section 
58-17b-304
, who is also licensed to
dispense a controlled substance under Title 58, Chapter 37, Utah Controlled Substances Act.
(b) "Outpatient" means a setting in which an individual visits a licensed healthcare
facility or a healthcare provider's office for a diagnosis or treatment but is not admitted to a
licensed healthcare facility for an overnight stay.
(c) "Prescriber" means an individual authorized to prescribe a controlled substance
under Title 58, Chapter 37, Utah Controlled Substances Act.
(d) "Schedule II opioid" means those substances listed in Subsection 
58-37-4
(2)(b)(i)
or (2)(b)(ii).
(e) "Schedule III opioid" means those substances listed in Subsection 
58-37-4
(2)(c)
that are opioids.
[
(2) (a) A prescriber shall substantially comply with this Subsection (2).
]
[
(b) Except as provided in Subsection (2)(b), a
]
(2) (a) A
 prescriber shall check the database for information about a patient before the
first time the prescriber gives a prescription to a patient for a Schedule II opioid or a Schedule
III opioid.
[
(c) A prescriber is not required to check the database under Subsection (2)(b) if:
]
[
(i) the prescription for a Schedule II opioid or a Schedule III opioid is for three days or
fewer on the daily dosage instructions on the prescription;
]
[
(ii) the prescriber has prior knowledge of the patient's prescription history based on
the prescriber's review of the patient's health record; or
]
[
(iii) the prescription for a Schedule II opioid or a Schedule III opioid is a post surgical
prescription and the total duration of opioid written after the surgery has been for 30 days or
fewer.
]
[
(d)
] 
(b)
 If a prescriber is repeatedly prescribing a Schedule II opioid or Schedule III
opioid to a patient, the prescriber shall periodically review information about the patient in:
(i) the database; or
(ii) other similar records of controlled substances the patient has filled.
[
(e)
] 
(c)
 A prescriber may assign the access and review required under [
Subsections
(2)(b) and (2)(c)
] 
Subsection (2)(a)
 to one or more employees in accordance with Subsections
58-37f-301
(2)(i) and (j).
[
(f) The division shall not take action against the license of a prescriber for failure to
follow this Subsection (2) if the prescriber demonstrates substantial compliance with the
requirements of this Subsection (2).
]
(d) (i) A prescriber may comply with the requirements in Subsections (2)(a) and (b) by
checking an electronic health record system if the electronic health record system:
(A) is connected to the database through a connection that has been approved by the
division; and
(B) displays the information from the database in a prominent manner for the
prescriber.
(ii) The division may not approve a connection to the database if the connection does
not satisfy the requirements established by the division under Section 
58-37f-301
.
(e) A prescriber is not in violation of the requirements of Subsection (2)(a) or (b) if the
failure to comply with Subsection (2)(a) or (b):
(i) is necessary due to an emergency situation;
(ii) is caused by a suspension or disruption in the operation of the database; or
(iii) is caused by a failure in the operation or availability of the Internet.
(f) The division may not take action against the license of a prescriber for failure to
comply with this Subsection (2) unless the failure occurs after the earlier of:
(i) December 31, 2018; or
(ii) the date that the division has the capability to establish a connection that meets the
requirements established by the division under Section 
58-37f-301
 between the database and an
electronic health record system.
(3) The division shall, in collaboration with the licensing boards for prescribers and
dispensers:
(a) develop a system that gathers and reports to prescribers and dispensers the progress
and results of the prescriber's and dispenser's individual access and review of the database, as
provided in this section; and
(b) reduce or waive the division's continuing education requirements regarding opioid
prescriptions, described in Section 
58-37-6.5
, including the online tutorial and test relating to
the database, for prescribers and dispensers whose individual utilization of the database, as
determined by the division, demonstrates substantial compliance with this section.
(4) If the dispenser's access and review of the database suggest that the individual
seeking an opioid may be obtaining opioids in quantities or frequencies inconsistent with
generally recognized standards as provided in this section and Section 
58-37f-201
, the
dispenser shall reasonably attempt to contact the prescriber to obtain the prescriber's informed,
current, and professional decision regarding whether the prescribed opioid is medically
justified, notwithstanding the results of the database search.
(5) (a) The division shall review the database to identify any prescriber who has a
pattern of prescribing opioids not in accordance with the recommendations of:
(i) the CDC Guideline for Prescribing Opioids for Chronic Pain, published by the
Centers for Disease Control and Prevention;
(ii) the Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain,
published by the Department of Health; or
(iii) other publications describing best practices related to prescribing opioids as
identified by division rule in accordance with Title 63G, Chapter 3, Utah Administrative
Rulemaking Act, and in consultation with the Physicians Licensing Board.
(b) The division shall offer education to a prescriber identified under this Subsection
(5) regarding best practices in the prescribing of opioids.
(c) A decision by a prescriber to accept or not accept the education offered by the
division under this Subsection (5) is voluntary.
(d) The division may not use an identification the division has made under this
Subsection (5) or the decision by a prescriber to accept or not accept education offered by the
division under this Subsection (5) in a licensing investigation or action by the division.
(e) Any record created by the division as a result of this Subsection (5) is a protected
record under Section 
63G-2-305
.
Section 2. Section 
58-37f-701
 is amended to read:
58-37f-701.
Immunity from liability.
(1) An individual who has submitted information to or accessed and reviewed the
database in accordance with this chapter may not be held civilly liable, including under Title
78B, Chapter 3, Part 4, Utah Health Care Malpractice Act, for such actions, or a lack of action,
which are protected and are not subject to civil discovery, as provided in Section 
58-37f-302
.
[
(2) Notwithstanding any other provision of law, any action or lack of action by a
prescriber or dispenser to meet the requirements of Section 
58-37f-304
 may not be used by the
division in any action against the prescriber or dispenser.
]
[
(3)
] 
(2)
 Nothing in Section 
58-37f-304
 establishes a minimum standard of care for
prescribers and dispensers.